Recombinant human monoclonal antibody to TGF beta 1.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human, Mouse
Host
Human
Clonality
Monoclonal
Isotype
IgG4SP - Human IgG4 with S228P mutation
Light Chains
kappa
Conjugate
Unconjugated
Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 144.4 kDa.
Purity
> 95% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
SDS-PAGE analysis of Fresolimumab Biosimilar - Anti-TGF beta 1 Antibody - Low endotoxin, Azide free (A323462) under reducing (R) conditions confirms that the purity of this antibody is greater than 95%.
SEC-HPLC analysis of Fresolimumab Biosimilar - Anti-TGF beta 1 Antibody - Low endotoxin, Azide free (A323462) confirms that the purity of this antibody is 97.38%.
Immobilized recombinant human latent TGF beta 1/TGFB 1 protein (His tag) at 2 µg/ml is bound by Fresolimumab Biosimilar - Anti-TGF beta 1 Antibody - Low endotoxin, Azide free (A323462). EC50 = 0.06648 µg/ml.
Publishing research using Fresolimumab Biosimilar - Anti-TGF beta 1 Antibody - Low endotoxin, Azide free (A323462)? Please let us know so that we can list the citation on this page.
Alternative products to Fresolimumab Biosimilar - Anti-TGF beta 1 Antibody - Low endotoxin, Azide free (A323462)